Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00876889 · ClinicalTrials.gov registry record
Safety of Riluzole in Patients With Acute Spinal Cord Injury
A clinical trial, sponsored by The Methodist Hospital Research Institute.
- Completed
- Registry status
- 36
- Enrollment target
NCT00876889: Completed study, sponsored by The Methodist Hospital Research Institute.
NCT00876889 is a clinical trial that has completed, run by The Methodist Hospital Research Institute. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00876889 has completed, sponsored by The Methodist Hospital Research Institute.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of the study is to find out if the use of the drug Riluzole is both safe and improves outcome in patients with acute traumatic spinal cord injury (SCI).
Primary Outcome
Neurological assessment and classification of spinal cord injury
Interventions
- DRUG Riluzole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-04 |
What the finished NCT00876889 record still lists
NCT00876889 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Riluzole is the first listed.
NCT00876889 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00876889 about?
NCT00876889 is a clinical study titled "Safety of Riluzole in Patients With Acute Spinal Cord Injury". The purpose of the study is to find out if the use of the drug Riluzole is both safe and improves outcome in patients with acute traumatic spinal cord injury (SCI).
What is the current status of trial NCT00876889?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2010-04. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00876889?
The interventions under investigation include: Riluzole (DRUG).
Who is sponsoring clinical trial NCT00876889?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia